BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7048901)

  • 21. [Pharmacokinetic interpretation of the nephrotoxic effect of aminoglycosides. Pharmacodynamic aspects of the nephrotoxic effect of aminoglycosides].
    Gagaeva EV; Firsov AA; Fomina IP
    Antibiot Khimioter; 1989 Apr; 34(4):304-8. PubMed ID: 2665678
    [No Abstract]   [Full Text] [Related]  

  • 22. Aminoglycoside-Related Nephrotoxicity and Ototoxicity in Clinical Practice: A Review of Pathophysiological Mechanism and Treatment Options.
    Le TA; Hiba T; Chaudhari D; Preston AN; Palowsky ZR; Ahmadzadeh S; Shekoohi S; Cornett EM; Kaye AD
    Adv Ther; 2023 Apr; 40(4):1357-1365. PubMed ID: 36738370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidant mechanisms in gentamicin nephrotoxicity.
    Walker PD; Barri Y; Shah SV
    Ren Fail; 1999; 21(3-4):433-42. PubMed ID: 10416224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular nephrotoxicity of aminoglycosides.
    Martínez-Salgado C; López-Hernández FJ; López-Novoa JM
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):86-98. PubMed ID: 17602717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular aspects of aminoglycoside nephrotoxicity].
    Konopska B; Warwas M
    Postepy Hig Med Dosw (Online); 2007 Sep; 61():511-8. PubMed ID: 17909519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular mechanisms underlying renal accumulation of aminoglycoside antibiotics and mechanism-based approach for developing nonnephrotoxic aminoglycoside therapy].
    Nagai J
    Yakugaku Zasshi; 2006 May; 126(5):327-35. PubMed ID: 16679740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevision of aminoglycoside nephrotoxicity (author's transl)].
    Lucht F; Peyramond D; Robert D; Vincent P
    Pathol Biol (Paris); 1982 Apr; 30(4):227-31. PubMed ID: 7045782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of risk factors for aminoglycoside nephrotoxicity.
    Smith CR; Moore RD; Lietman PS
    Am J Kidney Dis; 1986 Nov; 8(5):308-13. PubMed ID: 3538855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vancomycin nephrotoxicity: Frequency and mechanistic aspects].
    Luque Y; Mesnard L
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S133-S138. PubMed ID: 29606259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients.
    Schentag JJ; Cerra FB; Plaut ME
    Antimicrob Agents Chemother; 1982 May; 21(5):721-6. PubMed ID: 7103453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell biology of aminoglycoside nephrotoxicity: newer aspects.
    Molitoris BA
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):384-8. PubMed ID: 9263689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prediction of aminoglycoside nephrotoxicity].
    Lucht F; Peyramond D; Robert D; Vincent P
    Sem Hop; 1982 Sep; 58(35):2021-5. PubMed ID: 6293091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycoside nephrotoxicity--a tale of two transports.
    Whelton A; Solez K
    J Lab Clin Med; 1982 Feb; 99(2):148-55. PubMed ID: 7038007
    [No Abstract]   [Full Text] [Related]  

  • 35. [Aminoglycoside nephrotoxicity. III. Changes in subcellular elements].
    Fillastre JP; Morin JP; Bendirdjian JP; Viotte G; Godin M
    Nephrologie; 1980; 1(3):145-52. PubMed ID: 7027065
    [No Abstract]   [Full Text] [Related]  

  • 36. Lysosomal modifications in human proximal tubule induced by aminoglycoside treatment: visualisation by light microscopical cytochemistry.
    Roels F; Paulus G; De Broe ME
    Pathol Res Pract; 1984 Nov; 179(2):230-4. PubMed ID: 6522334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amelioration of aminoglycoside nephrotoxicity requires protection of renal mitochondria.
    Zorov DB
    Kidney Int; 2010 May; 77(10):841-3. PubMed ID: 20431573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic factors in aminoglycoside-induced nephrotoxicity.
    Kacew S; Bergeron MG
    Toxicol Lett; 1990 May; 51(3):241-59; discussion 237-9. PubMed ID: 2187280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cephalosporin-aminoglycoside synergistic nephrotoxicity: fact or fiction?
    Mannion JC; Bloch R; Popovich NG
    Drug Intell Clin Pharm; 1981 Apr; 15(4):248-56. PubMed ID: 7023896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoglycoside nephrotoxicity.
    Swan SK
    Semin Nephrol; 1997 Jan; 17(1):27-33. PubMed ID: 9000547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.